arginyl-glycyl-aspartic acid has been researched along with Squamous Cell Carcinoma of Head and Neck in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jiang, J; Lv, L; Lv, M; Shao, F; Wang, J; Wang, Y; Zheng, Y | 1 |
1 other study(ies) available for arginyl-glycyl-aspartic acid and Squamous Cell Carcinoma of Head and Neck
Article | Year |
---|---|
The anti-tumour activity of rLj-RGD4, an RGD toxin protein from Lampetra japonica, on human laryngeal squamous carcinoma Hep-2 cells in nude mice.
Topics: Amino Acid Motifs; Angiogenesis Inhibitors; Animals; Apoptosis; Body Weight; Carcinoma, Squamous Cell; Cell Line, Tumor; Fish Proteins; Fish Venoms; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Lampreys; Laryngeal Neoplasms; Marine Toxins; Mice, Nude; Microvessels; Oligopeptides; Random Allocation; Recombinant Proteins; Squamous Cell Carcinoma of Head and Neck; Survival Analysis; Tumor Burden; Xenograft Model Antitumor Assays | 2015 |